TRCT
GI

Tower Research Capital (TRC)’s EndoChoice Holdings, Inc. GI Stock Holding History

Tower Research Capital (TRC)’s Portfolio GI Stock Details GI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-1,574
Closed -$13K – 4921
2016
Q3 		$13K Buy
1,574
+1,380
+711% +$6.46K ﹤0.01% 1909
2016
Q2 		$1K Sell
194
-116
-37% -$553 ﹤0.01% 4334
2016
Q1 		$2K Sell
310
-196
-39% -$1.07K ﹤0.01% 3564
2015
Q4 		$4K Sell
506
-3,532
-87% -$33.9K ﹤0.01% 3343
2015
Q3 		$46K Buy
+4,038
New +$63.2K ﹤0.01% 1092

Tower Research Capital (TRC)'s GI Position: Q4 2016 in Review

Tower Research Capital (TRC) sold out of EndoChoice Holdings, Inc. (GI) in Q4 2016, closing a stake of 1,574 shares — an estimated $13K sold.

Tower Research Capital (TRC) first reported a position in GI in Q3 2015 and held it in 5 quarters. The position peaked at $46K in Q3 2015. 0 funds tracked by Wall St. Rank hold GI as of Q4 2016.

  • Tower Research Capital (TRC) reported no remaining EndoChoice Holdings, Inc. position as of Q4 2016 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 1,574 EndoChoice Holdings, Inc. shares in Q4 2016, an estimated $13K.
  • Tower Research Capital (TRC) first reported a position in EndoChoice Holdings, Inc. in Q3 2015 and held it in 5 quarters.
  • Tower Research Capital (TRC)'s EndoChoice Holdings, Inc. position peaked at $46K in Q3 2015.
  • 0 funds tracked by Wall St. Rank held EndoChoice Holdings, Inc. as of Q4 2016.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2016, filed 3 Feb 2017.